Trazodone is NOT Recommended for TMJ Disorder
Trazodone is not an evidence-based treatment for temporomandibular joint (TMJ) disorder and should not be used for this indication. The FDA-approved indication for trazodone is solely for major depressive disorder in adults 1, and there is no evidence supporting its use for TMJ-related pain.
Why Trazodone Doesn't Help TMJ
The most recent and comprehensive 2023 BMJ clinical practice guideline on chronic TMJ pain management does not include trazodone among any of its recommendations 2. This guideline, which systematically reviewed all available treatments using rigorous GRADE methodology, provides clear direction on what works and what doesn't.
What the Evidence Actually Shows
Strong recommendations IN FAVOR of 2:
- Cognitive behavioral therapy (with or without biofeedback)
- Therapist-assisted mobilization
- Manual trigger point therapy
- Supervised postural exercise
- Supervised jaw exercise and stretching
- Usual care (home exercises, stretching, reassurance, education)
Conditional recommendations AGAINST 2:
- Gabapentin (a neuromodulatory medication similar in class to what trazodone might theoretically address)
- Benzodiazepines
- β blockers
- Acetaminophen with muscle relaxants
The Medication Landscape for TMJ
While some older guidelines mention "neuromodulatory medications" like amitriptyline or gabapentin 2, the 2023 BMJ guideline specifically issued a conditional recommendation AGAINST gabapentin 2. This is significant because if gabapentin—which has more theoretical rationale for neuropathic pain—is not recommended, trazodone (which lacks any TMJ-specific evidence) certainly shouldn't be used.
Important Caveats
Trazodone carries significant risks that are particularly problematic in TMJ patients 1:
- Cardiac arrhythmias and QT prolongation
- Orthostatic hypotension and syncope
- Serotonin syndrome risk
- Drowsiness and sedation
These risks are not justified given the complete absence of evidence for benefit in TMJ disorders.
What TO Use Instead
Follow this algorithmic approach based on the 2023 BMJ guideline 2:
First-line (strongly recommended):
- Start with usual care: home jaw exercises, stretching, patient education, and reassurance
- Add cognitive behavioral therapy if available
- Consider supervised physical therapy with jaw exercises and manual trigger point therapy
Second-line (conditionally recommended in favor):
- Manipulation with postural exercise
- Acupuncture
- CBT combined with NSAIDs (not trazodone)
Avoid entirely 2:
- Irreversible oral splints
- NSAIDs with opioids (strong recommendation against)
- Most pharmacologic interventions have limited evidence
The evidence is clear: prioritize active, conservative, reversible interventions that require patient participation rather than medications like trazodone that lack any supporting evidence and carry unnecessary risks 2.